Prediction and Optimization of Pharmacokinetic and Toxicity Properties of the Ligand. (2018)
Attributed to:
Newton001 Understanding Antimicrobial Resistance Mutations in Tuberculosis: Towards Personalised Treatment to Combat Multi-drug Resistance
funded by
Newton Fund
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/978-1-4939-7756-7_14
PubMed Identifier: 29594777
Publication URI: http://europepmc.org/abstract/MED/29594777
Type: Journal Article/Review
Volume: 1762
Parent Publication: Methods in molecular biology (Clifton, N.J.)
ISSN: 1064-3745